Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History.

Prall OWJ, McEvoy CRE, Byrne DJ, Iravani A, Browning J, Choong DY, Yellapu B, O'Haire S, Smith K, Luen SJ, Mitchell PLR, Desai J, Fox SB, Fellowes A, Xu H.

Int J Surg Pathol. 2020 Jan 13:1066896919900548. doi: 10.1177/1066896919900548. [Epub ahead of print]

PMID:
31931637
2.

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.

McEvoy CR, Xu H, Smith K, Etemadmoghadam D, San Leong H, Choong DY, Byrne DJ, Iravani A, Beck S, Mileshkin L, Tothill RW, Bowtell DD, Bates BM, Nastevski V, Browning J, Bell AH, Khoo C, Desai J, Fellowes AP, Fox SB, Prall OW.

J Clin Invest. 2019 May 1;129(5):1940-1945. doi: 10.1172/JCI123089. Epub 2019 Mar 5.

3.

SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.

McEvoy CR, Koe L, Choong DY, Leong HS, Xu H, Karikios D, Plew JD, Prall OW, Fellowes AP, Fox SB.

NPJ Precis Oncol. 2018 Mar 20;2:9. doi: 10.1038/s41698-018-0053-2. eCollection 2018.

4.

Platelet-derived growth factor (PDGF) signaling directs cardiomyocyte movement toward the midline during heart tube assembly.

Bloomekatz J, Singh R, Prall OW, Dunn AC, Vaughan M, Loo CS, Harvey RP, Yelon D.

Elife. 2017 Jan 18;6. pii: e21172. doi: 10.7554/eLife.21172.

5.

Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.

Koss M, Bolze A, Brendolan A, Saggese M, Capellini TD, Bojilova E, Boisson B, Prall OW, Elliott DA, Solloway M, Lenti E, Hidaka C, Chang CP, Mahlaoui N, Harvey RP, Casanova JL, Selleri L.

Dev Cell. 2012 May 15;22(5):913-26. doi: 10.1016/j.devcel.2012.02.009. Epub 2012 May 3.

6.

Adult cardiac-resident MSC-like stem cells with a proepicardial origin.

Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ, Rashidianfar A, Biben C, Zoellner H, Colvin EK, Pimanda JE, Biankin AV, Zhou B, Pu WT, Prall OW, Harvey RP.

Cell Stem Cell. 2011 Dec 2;9(6):527-40. doi: 10.1016/j.stem.2011.10.002.

7.

NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.

Elliott DA, Braam SR, Koutsis K, Ng ES, Jenny R, Lagerqvist EL, Biben C, Hatzistavrou T, Hirst CE, Yu QC, Skelton RJ, Ward-van Oostwaard D, Lim SM, Khammy O, Li X, Hawes SM, Davis RP, Goulburn AL, Passier R, Prall OW, Haynes JM, Pouton CW, Kaye DM, Mummery CL, Elefanty AG, Stanley EG.

Nat Methods. 2011 Oct 23;8(12):1037-40. doi: 10.1038/nmeth.1740.

PMID:
22020065
8.

Zac1 is an essential transcription factor for cardiac morphogenesis.

Yuasa S, Onizuka T, Shimoji K, Ohno Y, Kageyama T, Yoon SH, Egashira T, Seki T, Hashimoto H, Nishiyama T, Kaneda R, Murata M, Hattori F, Makino S, Sano M, Ogawa S, Prall OW, Harvey RP, Fukuda K.

Circ Res. 2010 Apr 2;106(6):1083-91. doi: 10.1161/CIRCRESAHA.109.214130. Epub 2010 Feb 18.

PMID:
20167925
9.

RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression.

Yadava RS, Frenzel-McCardell CD, Yu Q, Srinivasan V, Tucker AL, Puymirat J, Thornton CA, Prall OW, Harvey RP, Mahadevan MS.

Nat Genet. 2008 Jan;40(1):61-8. Epub 2007 Dec 16.

10.

Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium.

Mommersteeg MT, Brown NA, Prall OW, de Gier-de Vries C, Harvey RP, Moorman AF, Christoffels VM.

Circ Res. 2007 Oct 26;101(9):902-9. Epub 2007 Sep 6.

PMID:
17823370
11.

An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation.

Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, Stennard FA, Wise N, Schaft D, Wolstein O, Furtado MB, Shiratori H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham ME, Harvey RP.

Cell. 2007 Mar 9;128(5):947-59.

12.

Molecular pathway for the localized formation of the sinoatrial node.

Mommersteeg MT, Hoogaars WM, Prall OW, de Gier-de Vries C, Wiese C, Clout DE, Papaioannou VE, Brown NA, Harvey RP, Moorman AF, Christoffels VM.

Circ Res. 2007 Feb 16;100(3):354-62. Epub 2007 Jan 18.

PMID:
17234970
13.

Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18.

Christoffels VM, Mommersteeg MT, Trowe MO, Prall OW, de Gier-de Vries C, Soufan AT, Bussen M, Schuster-Gossler K, Harvey RP, Moorman AF, Kispert A.

Circ Res. 2006 Jun 23;98(12):1555-63. Epub 2006 May 18.

PMID:
16709898
14.

Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1.

Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, Levy J, Sharoni Y.

Eur J Nutr. 2006 Aug;45(5):275-82. Epub 2006 Mar 24.

PMID:
16565789
15.

Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes.

Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kesteven SH, Guan Z, Prall OW, Mearns BM, Feneley MP, Steinberg SF, Graham RM.

J Mol Cell Cardiol. 2006 Apr;40(4):540-52. Epub 2006 Mar 6.

PMID:
16516910
16.

Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation.

Stennard FA, Costa MW, Lai D, Biben C, Furtado MB, Solloway MJ, McCulley DJ, Leimena C, Preis JI, Dunwoodie SL, Elliott DE, Prall OW, Black BL, Fatkin D, Harvey RP.

Development. 2005 May;132(10):2451-62. Epub 2005 Apr 20.

17.

Developmental paradigms in heart disease: insights from tinman.

Prall OW, Elliott DA, Harvey RP.

Ann Med. 2002;34(3):148-56. Review.

PMID:
12173684
18.

A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.

Prall OW, Carroll JS, Sutherland RL.

J Biol Chem. 2001 Nov 30;276(48):45433-42. Epub 2001 Oct 1.

22.

Estrogen and progestin regulation of cell cycle progression.

Sutherland RL, Prall OW, Watts CK, Musgrove EA.

J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):63-72. Review.

PMID:
10819505
23.

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.

Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL.

Oncogene. 1998 Aug 27;17(8):1053-9.

24.

Estrogen regulation of cell cycle progression in breast cancer cells.

Prall OW, Rogan EM, Sutherland RL.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):169-74. Review.

PMID:
9699870
25.

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL.

Mol Cell Biol. 1998 Aug;18(8):4499-508.

26.

Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.

Wilcken NR, Prall OW, Musgrove EA, Sutherland RL.

Clin Cancer Res. 1997 Jun;3(6):849-54.

Supplemental Content

Loading ...
Support Center